CureDuchenne Fuerza 2025, hosted by the CureDuchenne International Program on October 25, 2025, brought together more than 400 attendees with the goal of improving care for individuals with Duchenne and Becker muscular dystrophy. Over […]
Full-Day Conference Will Bring Education, Support, and Connection to Families and Healthcare Providers Serving the Duchenne and Becker Community Newport Beach, Calif., September 18, 2025 — CureDuchenne, a global leader […]
Event Proceeds Will Advance Research and Support the CureDuchenne Clinic within the Neuromuscular Program at Rady Children’s Health Orange County NEWPORT BEACH, California (September 19, 2025) – CureDuchenne, a global […]
Ribbon-Cutting Ceremony Marks a Major Step Forward in Expanding Access to Advanced Care and Cutting-Edge Treatment for Families Across Southern California NEWPORT BEACH, Calif. (September 15, 2025) – CureDuchenne and […]
Top Dallas Chefs and Napa Valley Wines Unite to Support Groundbreaking Research for Duchenne Muscular Dystrophy Dallas, TX – August 21, 2025 – CureDuchenne, a leading nonprofit dedicated to finding […]
Edgewise Therapeutics, which received early funding from CureDuchenne, has reported positive results in its sevasemten program for Becker and Duchenne muscular dystrophies. New open-label data in Becker from the MESA trial demonstrated […]
PepGen has ended clinical trials of PGN-EDO51, their investigational therapy for Duchenne patients amenable to skipping exon 51, as PGN-EDO51 failed to achieve target dystrophin levels in their CONNECT1 trial. The company intends […]
2025 MDA Conference Updates We’re at the 2025 MDA Clinical & Scientific Conference this week and are pleased to share research updates from companies presenting on the latest advancements in Duchenne muscular […]
Southern California’s Premier Wine Gala Set for March 1, 2025, at Pendry Newport Beach NEWPORT BEACH Calif., January 30, 2025– Esteemed for its unparalleled showcase of Napa Valley’s finest wines, […]
